Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
PHASE2
This is an investigator-initiated, prospective, multicenter, single-arm pha...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Phase II Study Comparing Conversion Rate to Surgery With Hepatic Arterial Infusion Chemotherapy to Systemic Chemotherapy in Patients With Non Resectable Liver-only Colorectal Metastases
PHASE2
Approximately 40% of colorectal cancer patients will develop colorectal liv...
Status
Unknown
Location
Severance Hospital, Yonsei University Health System